Immunoreactivity of glucose transporter 5 is located in epithelial cells of the choroid plexus and ependymal cells

- The expression level of mRNA and proteins of Glut5 is low in the brains of mice.
- An antibody for two regions of amino acid sequences of mouse Glut5 is custom-made.
- Immunoreactivity of Glut5 is located in the choroid plexus and ependyma.
- The immunoreactivity in membranes disappears by incubation with antigenic peptides.
- The immunoreactivity in sections disappears by incubation with antigenic peptides.

High fructose intake is associated with increased plasma triglyceride concentration, hepatic steatosis, impaired glucose tolerance, insulin resistance, and high blood pressure. In addition, increased fructose intake has recently been supposed to be a risk factor for dementia. However, direct effects of fructose on the brain function remain to be clarified. The localization of glucose transporter 5 (Glut5), a representative transporter of fructose, was immunohistochemically examined in the brains of humans, rats, and mice to clarify whether fructose was transported from the blood into the brain. Glut5 immunoreactivity was demonstrated to be located in the epithelial cells of the choroid plexus and the ependymal cells in the brains of humans and rats using commercial antibodies for Glut5. In addition, mRNA expression of mouse Glut5 was confirmed in the brains of mice. Immunohistochemical examination using a custom-made antibody against two regions of amino acid sequences of mouse Glut5 revealed that Glut5 immunoreactivity was also seen in the epithelial cells of the choroid plexus and the ependymal cells in the brains of mice. These findings show that Glut5 immunoreactivity is located in the epithelial cells of the choroid plexus and the ependymal cells, suggesting the possibility of the direct transportation of intravascular fructose into the brain parenchyma.